Abstract:Hypertrophic scars (HTSs) are aberrant structures that develop where skin is injured complexly and represent the result of a chronic inflammation as a healing response. To date, there is no satisfactory prevention option for HTSs, which is due to the complexity of multiple mechanisms behind the formation of these structures. The present work aimed to propose Biofiber (Biodegradable fiber), an advanced textured electrospun dressing, as a suitable solution for HTS formation in complex wounds. Biofiber has been designed as a 3-day long-term treatment to protect the healing environment and enhance wound care practices. Its textured matrix consists of homogeneous and well-interconnected Poly-L-lactide-co-poly-ε-caprolactone (PLA-PCL) electrospun fibers (size 3.825 ± 1.12 µm) loaded with Naringin (NG, 2.0% w/w), a natural antifibrotic agent. The structural units contribute to achieve an optimal fluid handling capacity demonstrated through a moderate hydrophobic wettability behavior (109.3 ± 2.3°), and a suitable balance between absorbency (389.8 ± 58.16%) and moisture vapor transmission rate (MVTR, 2645 ± 60.43 g/m2 day). The flexibility and conformability of Biofiber to the body surfaces is due to its innovative circular texture, that also allow it to obtain finer mechanical properties after 72 h in contact with Simulated Wound Fluid (SWF), with an elongation of 352.6 ± 36.10%, and a great tenacity (0.25 ± 0.03 Mpa). The ancillary action of NG results in a prolonged anti-fibrotic effect on Normal Human Dermal Fibroblasts (NHDF), through the controlled release of NG for 3 days. The prophylactic action was highlighted at day 3 with the down regulation of the major factors involved in the fibrotic process: Transforming Growth Factor β1 (TGF-β1), Collagen Type 1 alpha 1 chain (COL1A1), and α-smooth muscle actin (α-SMA). No significant anti-fibrotic effect has been demonstrated on Hypertrophic Human Fibroblasts derived from scars (HSF), proving the potential of Biofiber to minimize HTSs in the process of early wound healing as a prophylactic therapy.

Electrospun Ginsenoside Rg3/Poly(Lactic-Co-Glycolic Acid) Fibers Coated with Hyaluronic Acid for Repairing and Inhibiting Hypertrophic Scars

Electrospun poly(L-lactide) fiber with ginsenoside rg3 for inhibiting scar hyperplasia of skin.

Use of ginsenoside Rg3-loaded electrospun PLGA fibrous membranes as wound cover induces healing and inhibits hypertrophic scar formation of the skin

In vivo inhibition of hypertrophic scars by implantable ginsenoside-Rg3-loaded electrospun fibrous membranes.

Bionic Poly(γ-Glutamic Acid) Electrospun Fibrous Scaffolds for Preventing Hypertrophic Scars

Small Molecular TGF-β1-Inhibitor-Loaded Electrospun Fibrous Scaffolds for Preventing Hypertrophic Scars

Surface biofunctional drug-loaded electrospun fibrous scaffolds for comprehensive repairing hypertrophic scars.

Poly (γ‐glutamic Acid)/chitooligo‐saccharide/papain Hydrogel Prevents Hypertrophic Scar During Skin Wound Healing

In Vivo Early Intervention and the Therapeutic Effects of 20(S)-Ginsenoside Rg3 on Hypertrophic Scar Formation

3D printing of Rg3-loaded hydrogel scaffolds: anti-inflammatory and scar-formation related collagen inhibitory effects for scar-free wound healing

Advanced Wound Healing and Scar Reduction Using an Innovative Anti-ROS Polysaccharide Hydrogel with Recombinant Human Collagen Type III

Natural polymeric and peptide-loaded composite wound dressings for scar prevention

Topical Application of Silk Fibroin-Based Hydrogel in Preventing Hypertrophic Scars.

Electrospun Naringin-Loaded Fibers for Preventing Scar Formation during Wound Healing

The Inhibitory Effects of 20(R)-Ginsenoside Rg3 on the Proliferation, Angiogenesis, and Collagen Synthesis of Hypertrophic Scar Derived Fibroblasts in Vitro

Evaporation-based, co-axial lock-and-key fibrous reservoir for long-term prevention of hypertrophic scars

Three-dimensional Printing Bilayer Membranous Nanofiber Scaffold for Inhibiting Scar Hyperplasia of Skin

Rg3-loaded Biodegradable Composite Electrospun Fibers for Long-Term Inhibition of Hypertrophic Scarring.

Nano-in-micro Electronspun Membrane: Merging Nanocarriers and Microfibrous Scaffold for Long-Term Scar Inhibition

Layered dissolving microneedle containing a three-drug combination on the treatment of hypertrophic scar

Electrical and Immune Stimulation-Based Hydrogels Synergistically Realize Scarless Wound Healing Via Amplifying Endogenous Electrophysiological Function and Promoting Macrophage Phenotype-Switching